Key facts
- This page summarizes Monika Maria Toernsen's Form 4 filing for Passage BIO, Inc. (PASG).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Nov 2022, 16:01.
Monika Maria Toernsen - 15 Sep 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- PASG
- Reported as of
- 15 Sep 2022
- Net transaction value
- -$2,539
- SEC form
- 4
- Accepted by SEC
- 18 Nov 2022, 16:01:06 UTC
- Prior SEC filing
- 11 Jul 2022
- Next SEC filing
- 29 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edgar Cale, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Monika Maria Toernsen filed Form 4 for Passage BIO, Inc. (PASG) on 18 Nov 2022.
Change
- Previous filing in this sequence was filed on 11 Jul 2022.
- Current net transaction value: -$2,539.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PASG
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +5,000
- Change %
- Price
- Shares after
- 5,000
- Date
- 15 Sep 2022
- Ownership
- Direct
- Footnotes
- F1
PASG
transaction
Common Stock
Sale
- Transaction value
- $2,539
- Shares
- -1,681
- Change %
- -34%
- Price
- $1.51
- Shares after
- 3,319
- Date
- 19 Sep 2022
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PASG
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -5,000
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 15,000
- Date
- 15 Sep 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
Footnote F2
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Footnote F3
Each RSU represents a contingent right to receive one share of Issuer's common stock.
Footnote F4
1/4 of the RSUs vested on September 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.